Esomeprazole switching from Schedule II to Schedule III status in CanadaTo be available for self-selection for once-daily 14-day treatment of frequent heartburn New Canadian guidelines for treatment of Clostridium difficile infectionProvide recommendations for the management of initial and recurrent episodes Is ondansetron safe to use during pregnancy? Systematic review examines ondansetron safety for treating nausea and vomiting in pregnancy Can early exposure to anti-TNF therapy reduce the risk of Parkinson disease? Study suggests reducing systemic inflammation in patients with inflammatory bowel disease can also decrease the incidence of Parkinson disease 'Gliptin' use in type 2 diabetes may increase risk of developing inflammatory bowel disease Study authors suggest avoiding DPP-4 inhibitors in patients with a family history of inflammatory bowel disease and monitoring for persistent gastrointestinal symptoms Educational efforts reduce docusate use in hospitalized patients Alberta pharmacists reduce use of stool softener that has limited efficacy in preventing constipation Current management recommendations for Helicobacter pylori infections in adults Proton pump inhibitors linked to increased mortality May be time to restrict use of the drugs, say researchers Updated guidelines on dyspepsia management US/Canadian guidelines clarify tests for diagnosis and sequence of therapies New Canadian consensus guidelines on use of capsule endoscopy Recommendations focus on use in Crohn’s disease, celiac disease and GI bleeding First Previous 10 11 12 13 14 Next Last